IS2432B - Blanda sem má gefa inn í maga og garnir sem inniheldur seyði úr grænu tei og NO-gjafa - Google Patents

Blanda sem má gefa inn í maga og garnir sem inniheldur seyði úr grænu tei og NO-gjafa

Info

Publication number
IS2432B
IS2432B IS7836A IS7836A IS2432B IS 2432 B IS2432 B IS 2432B IS 7836 A IS7836 A IS 7836A IS 7836 A IS7836 A IS 7836A IS 2432 B IS2432 B IS 2432B
Authority
IS
Iceland
Prior art keywords
donor
green tea
stomach
injected
mixture
Prior art date
Application number
IS7836A
Other languages
English (en)
Other versions
IS7836A (is
Inventor
Schneider Heinz
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of IS7836A publication Critical patent/IS7836A/is
Publication of IS2432B publication Critical patent/IS2432B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7836A 2002-12-09 2005-05-03 Blanda sem má gefa inn í maga og garnir sem inniheldur seyði úr grænu tei og NO-gjafa IS2432B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10257360A DE10257360A1 (de) 2002-12-09 2002-12-09 Gastro-intestinal verabreichbare Formulierung und deren Verwendung
PCT/EP2003/012675 WO2004052352A1 (de) 2002-12-09 2003-11-13 Gastro-intestinal verabreichbare formulierung aus grüntee-extrakt und einen no-donor

Publications (2)

Publication Number Publication Date
IS7836A IS7836A (is) 2005-05-03
IS2432B true IS2432B (is) 2008-10-15

Family

ID=32477462

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7836A IS2432B (is) 2002-12-09 2005-05-03 Blanda sem má gefa inn í maga og garnir sem inniheldur seyði úr grænu tei og NO-gjafa

Country Status (24)

Country Link
US (1) US20060121125A1 (is)
EP (1) EP1572175B1 (is)
JP (1) JP2006510640A (is)
KR (1) KR101031989B1 (is)
CN (1) CN100367941C (is)
AT (1) ATE345116T1 (is)
AU (1) AU2003288047B2 (is)
BR (1) BRPI0315075A8 (is)
CA (1) CA2499006C (is)
DE (2) DE10257360A1 (is)
DK (1) DK1572175T3 (is)
ES (1) ES2276136T3 (is)
HK (1) HK1087913A1 (is)
HR (1) HRP20050511B1 (is)
IL (1) IL168854A (is)
IS (1) IS2432B (is)
MX (1) MXPA05006111A (is)
NO (1) NO332734B1 (is)
PL (1) PL212978B1 (is)
PT (1) PT1572175E (is)
RU (1) RU2314824C2 (is)
TW (1) TWI349563B (is)
WO (1) WO2004052352A1 (is)
ZA (1) ZA200501924B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
WO2014150996A1 (en) * 2013-03-15 2014-09-25 Cba Pharma, Inc. Cancer treatment
CN106061291A (zh) * 2013-12-18 2016-10-26 雅培公司 使用绿茶提取物来增加骨骼肌蛋白质合成的方法
US20210252423A1 (en) * 2018-06-21 2021-08-19 Gs Caltex Corporation Solvent composition for natural material extraction

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE502414C2 (sv) * 1990-05-28 1995-10-16 Ljungqvist Olle Medical Ab Användning av glukos för framställning av lösning för preoperativ administrering samt infusionslösning därför
GB9403935D0 (en) * 1994-03-01 1994-04-20 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JPH11501301A (ja) * 1995-02-23 1999-02-02 ノバルティス・ニュートリション・アクチエンゲゼルシャフト アミノ酸組成物および臨床的栄養補給におけるその使用
US5656608B1 (en) * 1995-02-23 2000-09-26 Novartis Nutrition Ltd Amino acid compositions and methods of treatment using same
GB9510037D0 (en) * 1995-05-18 1995-07-12 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JPH09227374A (ja) * 1996-02-28 1997-09-02 Taiyo Kagaku Co Ltd ストレスタンパク質産生抑制組成物
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
JPH10248538A (ja) * 1997-03-10 1998-09-22 Cheil Sugar Co Ltd α−波増進飲料用組成物及びこれを含有する飲料
EP0875155A1 (en) * 1997-05-01 1998-11-04 N.V. Nutricia Peri-operative drink
US6147109A (en) * 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
WO2000056403A1 (en) * 1999-03-19 2000-09-28 The Brigham And Women's Hospital, Inc. UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
EP1136073A1 (en) * 2000-03-22 2001-09-26 N.V. Nutricia Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
JP4908718B2 (ja) * 2000-07-05 2012-04-04 株式会社大塚製薬工場 細胞・組織保存液
EP1174143B1 (en) * 2000-07-14 2004-06-02 HealthEcon AG Green tea extract and use thereof in treating renal dysfunction induced by cyclosporins or ascomycins
US6423349B1 (en) * 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery

Also Published As

Publication number Publication date
RU2314824C2 (ru) 2008-01-20
NO20052978D0 (no) 2005-06-17
WO2004052352A1 (de) 2004-06-24
NO20052978L (no) 2005-06-17
IL168854A (en) 2011-09-27
HK1087913A1 (en) 2006-10-27
CN100367941C (zh) 2008-02-13
ATE345116T1 (de) 2006-12-15
BR0315075A (pt) 2005-08-16
TWI349563B (en) 2011-10-01
HRP20050511B1 (en) 2008-01-31
NO332734B1 (no) 2012-12-27
PL375734A1 (en) 2005-12-12
EP1572175A1 (de) 2005-09-14
IS7836A (is) 2005-05-03
US20060121125A1 (en) 2006-06-08
CN1703210A (zh) 2005-11-30
ZA200501924B (en) 2005-11-30
ES2276136T3 (es) 2007-06-16
RU2005111766A (ru) 2005-09-10
KR101031989B1 (ko) 2011-05-02
EP1572175B1 (de) 2006-11-15
DE10257360A1 (de) 2004-07-08
CA2499006A1 (en) 2004-06-24
JP2006510640A (ja) 2006-03-30
PT1572175E (pt) 2007-01-31
AU2003288047A1 (en) 2004-06-30
CA2499006C (en) 2011-04-19
AU2003288047B2 (en) 2008-03-13
HRP20050511A2 (en) 2005-10-31
MXPA05006111A (es) 2005-08-16
KR20050084207A (ko) 2005-08-26
TW200418501A (en) 2004-10-01
DE50305714D1 (de) 2006-12-28
DK1572175T3 (da) 2007-03-19
PL212978B1 (pl) 2012-12-31
BRPI0315075A8 (pt) 2017-12-19

Similar Documents

Publication Publication Date Title
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
MXPA03001116A (es) Estuche quirurgico para procedimientos de gastrostomia endoscopica percutanea de tipo de empuje.
IS7836A (is) Blanda sem má gefa inn í maga og garnir sem inniheldur seyði úr grænu tei og NO-gjafa
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
MXPA03001118A (es) Estuche quirurgico para procedimientos de gastrostomia endoscopica percutanea de tipo de "jalado".
WO2006012213A3 (en) Composition and method for delivery of phytochemicals
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
TW200503735A (en) Composition and method for viral inhibition
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
WO2005034861A3 (en) A dried biotherapeutic composition, uses, and device and methods for administration thereof
IS8107A (is) Lyfjablanda til inngjafar um munn sem felur í sérróteindadælumótlyf og basískt burðarefni
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
WO2001091769A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
NO20034829L (no) Fremgangsmåte for levering av frisk smak i en drikk laget på- stedet
WO2001045695A3 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
HK1057489A1 (en) Medicament for treating chronic hepatitis b
WO2002019842A3 (de) Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung
TW200621304A (en) Pharmaceutical composition
TW200621224A (en) Pharmaceutical composition
AU2003231481A1 (en) Use of berberine with high solubility in preparation of medicament
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
WO2004034993A3 (en) Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
EP1513512A4 (en) SOLUBLE STABLE PHARMACEUTICAL COMPOSITION FOR THE ADMINISTRATION OF HIV PROTEASE INHIBITORS AND METHOD FOR THE PREPARATION OF CONCENTRATED PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF HIV PROTEASE INHIBITORS.
WO2006002887A8 (en) Aqueous drink solution of indibulin (d-24851) and an organic acid